CELLnLIFE inc.
HISTORY
2021
Apr.
May.
Jun.
Jul.
Nov.
Selected for the disease-focused translational research project by the Ministry of Health and Welfare
-
Selected as a baby unicorn company by the Ministry of SMEs and Startups
-
Certified as a Frontier Venture Company
Completed GMP manufacturing facility in Guro, Seoul
-
Approval of aGVHD phase 1 clinical trial for adults by the Ministry of Food and Drug-Safety
-
Awarded the 15th Korea Excellent Patent Grand Prize by Hankook Ilbo
Awarded the 3rd Korea Small and Medium Business startup Grand Prize by Korea Venture Capital Association
2020
May.
Jun.
Oct.
Nov.
Selected as an innovative growth support company in the big 3 fields by the Ministry of SMEs and Startups
Selected for the research manpower support project for technology innovative SMEs by the Ministry of SMEs and Startups
Series A investment
-
Selected for the SME technology innovation development project by the Ministry of SMEs and Startups
-
Moved the business site (Guro-gu, seoul) and operated the SEOUL BIOHUB branch
2019
Apr.
Nov.
Technology transfer contract from Samsung Seoul Hospital
-
Selected for the startup growth technology development project by the Ministry of SMEs and Startups
-
Selected for the bio/medical technology commercialization support project by Seoul Business Agency
2018
Aug.
Sep.
Dec.
Established CellnLife corporation and selected as a resident company for SEOUL BIOHUB
Accredited as a business-affiliated research institute by KOITA
-
Certified as a Venture company by Korea Technology Finance Corporation
-
Selected for the research manpower support project for technology innovative SMEs by the Ministry of SMEs and Startups
2022
Jan.
Apr.
Jun.
Jul.
Selected as the 7th IBK CHANGGONG innovative start-up company in Guro
Selected for the R&D projects by Korean Fund for Regenerative Medicine
Selected for the basic research project by the Ministry of Science and ICT
Graduated from SEOUL BIOHUB startup incubator (4 years)

